Safety and Effectiveness of an Immunobiological Drug in CoViD-19
Clinical trial NCT04913779 · UNKNOWN
Trial details
- NCT number
- NCT04913779
- Sponsor
- Administracion Nacional de Laboratorios e Institutos de Salud Dr. Carlos G. Malbran
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-01
- Primary completion
- 2021-11-30
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.